Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from JBM (Healthcare) Ltd. ( (HK:2161) ) is now available.
JBM (Healthcare) Limited has announced the re-designation of Mr. Sum Kwong Yip, Derek, and Mr. Yim Chun Leung from non-executive to executive directors, effective June 12, 2025. This move is expected to enhance the company’s strategic direction and operational management, leveraging the extensive experience of both individuals in the pharmaceutical and corporate finance fields.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited operates in the healthcare industry, focusing on pharmaceutical products and services. The company is involved in strategic planning and development within the pharmaceutical sector, leveraging extensive experience in sales and corporate management.
Average Trading Volume: 1,275,497
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
For detailed information about 2161 stock, go to TipRanks’ Stock Analysis page.